Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Imunon, Inc. - Common Stock
(NQ:
IMNN
)
0.8004
-0.0096 (-1.19%)
Streaming Delayed Price
Updated: 11:53 AM EST, Nov 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Imunon, Inc. - Common Stock
< Previous
1
2
Next >
12 Health Care Stocks Moving In Thursday's Pre-Market Session
September 28, 2023
Via
Benzinga
Earnings Outlook For Imunon
August 09, 2023
Via
Benzinga
Imunon: Q1 Earnings Insights
May 11, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
April 03, 2023
On Monday, 76 companies set new 52-week lows.
Via
Benzinga
Imunon, Inc. - Common Stock Earnings Perspective: Return On Capital Employed
March 31, 2023
Via
Benzinga
Imunon, Inc. - Common Stock Earnings Preview
March 29, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 30, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
March 02, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 31, 2023
Via
Benzinga
Imunon, Inc. - Common Stock's Return On Capital Employed Overview
December 23, 2022
Via
Benzinga
IMUNON Reports Inducement Grants under NASDQ Listing Rule 5646(c)(4)
December 14, 2022
From
Imunon, Inc.
Via
GlobeNewswire
IMUNON Presentation at World Vaccine & Immunotherapy Congress Highlights PLACCINE Preclinical Proof of Concept and Key Competitive Advantages
December 01, 2022
From
Imunon, Inc.
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Wednesday
November 30, 2022
During Wednesday's session, 107 stocks hit new 52-week lows.
Via
Benzinga
IMUNON to Participate in the A.G.P./Alliance Global Partners Virtual Biotech Conference on November 30, 2022 – December 1, 2022
November 22, 2022
From
Imunon, Inc.
Via
GlobeNewswire
IMUNON Announces Strategic Investment in Transomic Technologies
November 17, 2022
From
Imunon, Inc.
Via
GlobeNewswire
IMUNON Reports Third Quarter 2022 Financial Results and Provides Business Update
November 14, 2022
From
Imunon, Inc.
Via
GlobeNewswire
IMUNON Enters into Technology Evaluation Agreement with Acuitas Therapeutics to Evaluate IMUNON’s PLACCINE Plasmid DNA with Acuitas’ Lipid Nanoparticle Delivery System
November 10, 2022
From
Imunon, Inc.
Via
GlobeNewswire
Imunon to Hold Third Quarter 2022 Financial Results and Business Update Conference Call on Monday, November 14, 2022
November 07, 2022
From
Imunon, Inc.
Via
GlobeNewswire
Imunon Appoints James E. Dentzer to its Board of Directors
October 03, 2022
From
Imunon, Inc.
Via
GlobeNewswire
Imunon Reports Partial Results from Ongoing Non-human Primate Study
October 03, 2022
From
Imunon, Inc.
Via
GlobeNewswire
Imunon Reports Inducement Grants under NASDQ Listing Rule 5646(c)(4)
September 29, 2022
From
Imunon, Inc.
Via
GlobeNewswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
